Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How much will it cost us? But Riley Griffin and Emma Court report that the Pharmaceutical industry is hoping Covid-19 will give it a chance to rebrand; and get the focus off drug prices.

<p>Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How much will it cost us? But Riley Griffin and Emma Court report that the Pharmaceutical industry is hoping Covid-19 will give it a chance to rebrand; and get the focus off drug prices.</p>

For much of human history, we’ve turned to diets to lose weight and improve our health. But it’s mostly been in vain. No matter how much the number on the scale drops begins to go down, chances are that the weight will come back. That’s just what the science says. But when it comes to weight, the facts just don’t seem to matter. Losing It, a new series from Bloomberg’s Prognosis, looks at how we got weight loss so wrong — and whether there’s a better way forward.

<p>For much of human history, we’ve turned to diets to lose weight and improve our health. But it’s mostly been in vain. No matter how much the number on the scale drops begins to go down, chances are that the weight will come back. That’s just what the science says. But when it comes to weight, the facts just don’t seem to matter. Losing It, a new series from Bloomberg’s Prognosis, looks at how we got weight loss so wrong — and whether there’s a better way forward.</p>

Prognosis: Losing it

Prognosis: Losing It

Learning to Love Big Pharma

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/f12f184c-b83d-4020-bce5-ae390093e759/transcript

Advertisement